By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Clal Biotechnology Industries Ltd. (CBI) 



Tel Aviv      Israel
Phone: N/A Fax:


SEARCH JOBS








Company News
Hyperion Therapeutics (HPTX) Enters Into Completion Of Phase III Clinical Trial, Option And Mutual Release Agreement With Clal Biotechnology Industries And Yeda Research and Development Company Ltd. 2/17/2015 7:22:49 AM
Hyperion Therapeutics (HPTX), Clal Biotechnology Industries Resolve Dispute Over $570 Million Biotech Problem 10/7/2014 7:16:31 AM
Clal Biotechnology Industries Release: Andromeda Announces That Further Data Analyses Support Primary Endpoint in Andromeda Biotech's Phase III Clinical Study 5/10/2012 10:15:06 AM
Teva Pharmaceutical Industries Limited (TEVA), Clal Biotechnology Industries Raises Stake in Diabetes Treatment Developer, Andromeda; Teva and Clal to Invest $17.5 Million 6/14/2010 6:45:58 AM
Yissum Ltd., Pontifax, and Clal Biotechnology Industries Invest $9 Million in Avraham Pharmaceuticals Ltd. to Pursue a Phase IIb Clinical Trial of Ladostigil, a Novel Drug for Treatment of Alzheimer's Disease 4/14/2010 6:40:38 AM
Arte Ventures And Clal Biotechnology Industries Introduce A New Model For Biotech Investment Management 3/27/2006 1:08:30 PM
Teva Pharmaceutical Industries Limited (TEVA) Buys 19% Of Clal Biotechnology Industries For $19 Million10/19/2005 5:09:17 PM
//-->